WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+2.4%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$6.81B
AUM Growth
+$684M
(+11%)
Cap. Flow
+$636M
Cap. Flow
% of AUM
9.34%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
980
New
186
Increased
207
Reduced
145
Closed
238
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$129M |
| 2 |
Gilead Sciences
GILD
|
$114M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$92.7M |
| 4 |
Amazon
AMZN
|
$77.2M |
| 5 |
Analog Devices
ADI
|
$70.5M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$74.7M |
| 2 |
Palo Alto Networks
PANW
|
$59.8M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$55.4M |
| 4 |
Alkermes
ALKS
|
$55.3M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$53.9M |
Sector Composition
| 1 | Healthcare | 37.87% |
| 2 | Technology | 30.7% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 8.09% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Acadia Pharmaceuticals
ACAD
$4.26B
| $6.47M | 0.09% |
395,549
+135,582
| +52% | +$2.22M |
|
|
FRXB
252
DELISTED
Forest Road Acquisition Corp. II
FRXB
| $6.39M | 0.09% |
650,000
+150,000
| +30% | +$1.47M |
|
253
Chewy
CHWY
$17.5B
| $6.37M | 0.09% |
+207,465
| New | +$6.37M |
|
254
Ardelyx
ARDX
$1.57B
| $6.35M | 0.09% |
+5,339,065
| New | +$6.35M |
|
|
LATG
255
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
| $6.31M | 0.09% |
625,001
+25,001
| +4% | +$252K |
|
|
KNTE
256
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $6.27M | 0.09% |
524,669
+264,393
| +102% | +$3.16M |
|
|
KVSC
257
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $6.22M | 0.09% |
635,700
+416,700
| +190% | +$4.08M |
|
258
Larimar Therapeutics
LRMR
$337M
| $6.21M | 0.09% |
+1,941,739
| New | +$6.21M |
|
|
BPMC
259
DELISTED
Blueprint Medicines
BPMC
| $6.15M | 0.09% |
93,387
-22,700
| -20% | -$1.5M |
|
260
Appian
APPN
$2.26B
| $6.09M | 0.09% |
149,121
+25,397
| +21% | +$1.04M |
|
261
argenx
ARGX
$45.9B
| $6.09M | 0.09% |
17,236
-9,948
| -37% | -$3.51M |
|
|
KDNY
262
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $6.08M | 0.09% |
309,384
-91,639
| -23% | -$1.8M |
|
263
Viridian Therapeutics
VRDN
$1.53B
| $6.07M | 0.08% |
295,874
-256,497
| -46% | -$5.26M |
|
|
TWOA
264
DELISTED
two
TWOA
| $6.07M | 0.08% |
613,114
+313,114
| +104% | +$3.1M |
|
265
DocuSign
DOCU
$16.1B
| $5.97M | 0.08% |
+111,604
| New | +$5.97M |
|
266
Elastic
ESTC
$9.21B
| $5.94M | 0.08% |
82,760
-492,099
| -86% | -$35.3M |
|
267
Spotify
SPOT
$146B
| $5.77M | 0.08% |
66,829
-45,195
| -40% | -$3.9M |
|
268
American Well
AMWL
$113M
| $5.74M | 0.08% |
79,915
+58,612
| +275% | +$4.21M |
|
269
MannKind Corp
MNKD
$1.7B
| $5.72M | 0.08% |
+1,849,389
| New | +$5.72M |
|
|
HTPA
270
DELISTED
Highland Transcend Partners I Corp.
HTPA
| $5.6M | 0.08% |
+562,500
| New | +$5.6M |
|
|
HAIA
271
DELISTED
Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
| $5.55M | 0.08% |
550,000
+250,000
| +83% | +$2.52M |
|
272
TG Therapeutics
TGTX
$5.11B
| $5.53M | 0.08% |
+934,436
| New | +$5.53M |
|
|
AFMD
273
DELISTED
Affimed
AFMD
| $5.42M | 0.08% |
263,169
+12,161
| +5% | +$251K |
|
274
Janux Therapeutics
JANX
$1.44B
| $5.42M | 0.08% |
400,181
+113,798
| +40% | +$1.54M |
|
275
Perrigo
PRGO
$3.12B
| $5.41M | 0.08% |
151,639
-500,724
| -77% | -$17.9M |
|